Stocks and Investing Stocks and Investing
Tue, April 27, 2021
Mon, April 26, 2021

Mark Breidenbach Initiated (ACHL) at Buy and Held Target at $23 on, Apr 26th, 2021


Published on 2024-10-27 16:22:47 - WOPRAI, Mark Breidenbach
  Print publication without navigation


Mark Breidenbach of Oppenheimer, Initiated "Achilles Therapeutics plc" (ACHL) at Buy and Held Target at $23 on, Apr 26th, 2021.

Mark, nor any peers, have made any analyst calls on ACHL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources